InvestorsHub Logo
Followers 8
Posts 389
Boards Moderated 0
Alias Born 02/12/2009

Re: 82090 post# 40974

Tuesday, 09/01/2009 2:46:21 PM

Tuesday, September 01, 2009 2:46:21 PM

Post# of 345950
82090: I'm sorry to hear about your friend. I not qualified to say how this company's product may or may not help your friend. The best thing to do is to contact Peregrine Pharmaceuticals directly using the links below obtained from PPHM website. This info was obtained from:

http://www.peregrineinc.com/index.php?option=com_content&task=view&id=22&Itemid=39

"If you are a health care provider interested in referring a patient or learning more about these clinical trials, please send an email correspondence to Peregrine Pharmaceuticals at

clinicalaffairs@peregrineinc.com

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it or visit

ClinicalTrials.gov.

If you are a patient interested in participating in one of these trials, please have your personal physician send an email correspondence to Peregrine."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News